Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|October 2, 2020
Out of Our Control: A Psychiatrist's Experience with Coronavirus
Author(s)Jack Turban, MD, MHS
There are things within our control: catching coronavirus may not be one of them.
Advertisement
Dr Turban is a resident physician in adult-child and adolescent psychiatry, Massachusetts General Hospital and McLean Hospital, Belmont, MA.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
2
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
3
New Phase 2 Data on Bezisterim for the Treatment of Long COVID
4
When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice
5